NO874495L - Ekspresjon av protein c. - Google Patents
Ekspresjon av protein c.Info
- Publication number
- NO874495L NO874495L NO87874495A NO874495A NO874495L NO 874495 L NO874495 L NO 874495L NO 87874495 A NO87874495 A NO 87874495A NO 874495 A NO874495 A NO 874495A NO 874495 L NO874495 L NO 874495L
- Authority
- NO
- Norway
- Prior art keywords
- protein
- disclosed
- mammalian host
- biological activity
- human protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6429—Thrombin (3.4.21.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6464—Protein C (3.4.21.69)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/848—Escherichia
- Y10S435/849—Escherichia coli
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/924,462 US4959318A (en) | 1985-06-27 | 1986-10-29 | Expression of protein C |
Publications (4)
Publication Number | Publication Date |
---|---|
NO874495D0 NO874495D0 (no) | 1987-10-28 |
NO874495L true NO874495L (no) | 1988-05-02 |
NO173741B NO173741B (no) | 1993-10-18 |
NO173741C NO173741C (no) | 1994-01-26 |
Family
ID=25450229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO874495A NO173741C (no) | 1986-10-29 | 1987-10-28 | DNA-sekvens for modifisert protein C, vektor inneholdende denne, patte-dyrceller transfektert med vektorer, og fremgangsmaate for fremstilling av nevnte protein |
Country Status (9)
Country | Link |
---|---|
US (1) | US4959318A (no) |
EP (1) | EP0266190B1 (no) |
JP (2) | JP2561677B2 (no) |
KR (1) | KR970002166B1 (no) |
AT (1) | ATE90966T1 (no) |
CA (1) | CA1340263C (no) |
DE (1) | DE3786321T2 (no) |
DK (1) | DK175183B1 (no) |
NO (1) | NO173741C (no) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5516650A (en) * | 1985-06-27 | 1996-05-14 | Zymogenetics, Inc. | Production of activated protein C |
US5550036A (en) * | 1986-04-09 | 1996-08-27 | Eli Lilly And Company | Method for co-amplification of human protein C genes in human cells |
US5422260A (en) * | 1986-05-29 | 1995-06-06 | Genetics Institute, Inc. -Legal Affairs | Human factor VIII:c muteins |
AU8339187A (en) * | 1986-11-17 | 1988-06-16 | New England Medical Center Hospitals, Inc., The | Enhancing gamma-carboxylation of recombinant vitamin k-dependent proteins |
EP0296413A2 (en) * | 1987-06-12 | 1988-12-28 | Hoechst Japan Limited | Hybrid protein C and method for its preparation |
US4992373A (en) * | 1987-12-04 | 1991-02-12 | Eli Lilly And Company | Vectors and compounds for direct expression of activated human protein C |
JP2728240B2 (ja) * | 1988-07-26 | 1998-03-18 | ヘキスト薬品工業株式会社 | ヒトプロテインc変異体及びその製造方法 |
US5571691A (en) * | 1989-05-05 | 1996-11-05 | Baylor College Of Medicine | Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms |
US6100054A (en) * | 1989-05-05 | 2000-08-08 | Baylor College Of Medicine | Production for recombinant lactoferrin and lactoferrin polypeptides using DNA sequences in various organisms |
US5849881A (en) * | 1989-05-05 | 1998-12-15 | Baylor College Medicine | Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms |
IL94183A (en) | 1989-05-05 | 2003-09-17 | Baylor College Medicine | cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE |
US5571697A (en) * | 1989-05-05 | 1996-11-05 | Baylor College Of Medicine Texas Medical Center | Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in Aspergillus |
US5766939A (en) * | 1989-05-05 | 1998-06-16 | Baylor College Of Medicine | Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms |
CA2064774C (en) * | 1989-08-11 | 2000-01-11 | Anur A. Kumar | Culture methods for producing activated protein c |
JP2774156B2 (ja) * | 1989-09-05 | 1998-07-09 | 帝人株式会社 | ヒトプロテインcおよび/または活性化ヒトプロテインc様活性を有する蛋白 |
JP2774163B2 (ja) * | 1989-11-14 | 1998-07-09 | 帝人株式会社 | ヒトプロテインc様活性を有する蛋白 |
JP3153236B2 (ja) * | 1989-12-22 | 2001-04-03 | ザイモジェネティクス,インコーポレイティド | 端が切り取られた軽鎖を有する組換えプロテインc |
US5358932A (en) * | 1989-12-29 | 1994-10-25 | Zymogenetics, Inc. | Hybrid protein C |
ATE163048T1 (de) * | 1989-12-29 | 1998-02-15 | Zymogenetics Inc | Hybrides protein c |
US5225537A (en) * | 1989-12-29 | 1993-07-06 | Zymogenetics, Inc. | Methods for producing hybrid phospholipid-binding proteins |
DE69131292T2 (de) * | 1990-01-29 | 1999-09-30 | Zymogenetics Inc | Antikoagulierende proteine |
IL97311A0 (en) * | 1990-02-23 | 1992-05-25 | Lilly Co Eli | Vectors and compounds for expression of glycosylation mutants of human protein c |
US5326700A (en) * | 1990-11-06 | 1994-07-05 | Eli Lilly And Company | DNA sequences encoding t-PA derivatives with cleavable sites |
US5831141A (en) * | 1991-01-11 | 1998-11-03 | United States Of America As Represented By The Department Of Health And Human Services | Expression of a heterologous polypeptide in mammary tissue of transgenic non-human mammals using a long whey acidic protein promoter |
US5965789A (en) * | 1991-01-11 | 1999-10-12 | American Red Cross | Engineering protein posttranslational modification by PACE/furin in transgenic non-human mammals |
US6262336B1 (en) | 1991-01-11 | 2001-07-17 | American Red Cross | Expression of a heterologous protein C in mammary tissue of transgenic animals using a long whey acidic protein promoter |
US5272078A (en) * | 1991-01-29 | 1993-12-21 | Brigham And Women's Hospital | CDNA encoding the type I iodothyronine 5'deiodinase |
AU1337092A (en) * | 1991-01-29 | 1992-08-27 | Brigham And Women's Hospital | A cdna encoding the type i iodothyronine 5' deiodinase |
CA2078667A1 (en) * | 1991-01-29 | 1992-07-30 | Masahiko Suzuki | Human protein c expression vector |
US5833982A (en) * | 1991-02-28 | 1998-11-10 | Zymogenetics, Inc. | Modified factor VII |
US5788965A (en) * | 1991-02-28 | 1998-08-04 | Novo Nordisk A/S | Modified factor VII |
US5997864A (en) | 1995-06-07 | 1999-12-07 | Novo Nordisk A/S | Modified factor VII |
US5876985A (en) * | 1991-04-25 | 1999-03-02 | Board Of Regents, The University Of Texas System | Methods and compositions for the preparation of recombinant Trichomonas vaginalis proteins and peptides |
AT402263B (de) * | 1991-06-20 | 1997-03-25 | Immuno Ag | Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz |
US6039944A (en) * | 1992-02-28 | 2000-03-21 | Zymogenetics, Inc. | Modified Factor VII |
DE4229933A1 (de) * | 1992-09-08 | 1994-03-10 | Max Planck Gesellschaft | Verfahren zur Bestimmung von Thrombose verursachenden Lupus-anticoagulant-Antikörpern |
US5618714A (en) * | 1993-12-15 | 1997-04-08 | Eli Lilly And Company | Methods for producing protein C |
AT403167B (de) * | 1994-11-14 | 1997-11-25 | Immuno Ag | Selektion und expression von fremdproteinen mittels eines selektions-amplifikations-systems |
US5905185A (en) * | 1995-11-30 | 1999-05-18 | Ppl Therapeutics | Protein C production in non-human transgenic mammals |
US6111081A (en) * | 1996-05-31 | 2000-08-29 | Baylor College Of Medicine | Lactoferrin variants and uses thereof |
DE69735597T2 (de) * | 1996-11-08 | 2006-12-21 | Oklahoma Medical Research Foundation, Oklahoma | Verwendung eines modifizierten protein-c |
US6165771A (en) * | 1997-06-10 | 2000-12-26 | Smithkline Beecham, P.L.C. | Compounds |
US6924359B1 (en) * | 1999-07-01 | 2005-08-02 | Yale University | Neovascular-targeted immunoconjugates |
AU2002210388B2 (en) * | 2000-10-18 | 2006-11-23 | Perseid Therapeutics Llc | Protein C or activated protein C like molecules |
US6933367B2 (en) * | 2000-10-18 | 2005-08-23 | Maxygen Aps | Protein C or activated protein C-like molecules |
US20070142272A1 (en) * | 2003-01-24 | 2007-06-21 | Zlokovic Berislav V | Neuroprotective activity of activated protein c independent of its anticoagulant activity |
WO2004113385A1 (en) * | 2003-06-20 | 2004-12-29 | Maxygen Holdings Ltd. | Protein c propeptide variants |
JP2008507561A (ja) * | 2004-07-23 | 2008-03-13 | ザ ユニバーシティ オブ ロチェスター | 活性化プロテインcによる、脳内のプラスミノゲン活性化因子の不都合な作用の阻害 |
RU2469093C2 (ru) * | 2008-12-19 | 2012-12-10 | Общество с ограниченной ответственностью "Лаборатория медицинской биотехнологии" (ООО "ЛМБТ") | ЭКСПРЕССИОННАЯ ПЛАЗМИДНАЯ ДНК pCID-PROC, КОДИРУЮЩАЯ ПРОТЕИН С ЧЕЛОВЕКА, И КЛЕТОЧНАЯ ЛИНИЯ DG-CID-PROC-1, ПРОДУЦИРУЮЩАЯ РЕКОМБИНАНТНЫЙ ПРОТЕИН С ЧЕЛОВЕКА |
WO2014005183A1 (en) | 2012-07-04 | 2014-01-09 | The University Of Sydney | Treatment of inflammatory skin disorders |
CN106573040B (zh) | 2014-04-16 | 2021-07-06 | Zz生物技术有限责任公司 | 治疗异常皮肤瘢痕形成 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8319538D0 (en) * | 1983-07-20 | 1983-08-24 | Beecham Group Plc | Compounds |
GB8327860D0 (en) * | 1983-10-18 | 1983-11-16 | Fujisawa Pharmaceutical Co | Monoclonal antiprotein c antibody |
US4775624A (en) * | 1985-02-08 | 1988-10-04 | Eli Lilly And Company | Vectors and compounds for expression of human protein C |
GR860984B (en) * | 1985-04-17 | 1986-08-18 | Zymogenetics Inc | Expression of factor vii and ix activities in mammalian cells |
DE3684546D1 (de) * | 1985-04-22 | 1992-04-30 | Genetics Inst | Herstellung mit hoher leistung des aktivfaktors ix. |
IL78571A (en) * | 1985-04-22 | 1991-06-30 | Genentech Inc | Human tissue plasminogen activator mutants resistant to enzymatic cleavage resulting in two-chain form |
DE3688900T3 (de) * | 1985-06-27 | 1998-06-10 | Zymogenetics Inc | Expression von Protein C. |
-
1986
- 1986-10-29 US US06/924,462 patent/US4959318A/en not_active Expired - Lifetime
-
1987
- 1987-10-28 EP EP87309528A patent/EP0266190B1/en not_active Expired - Lifetime
- 1987-10-28 NO NO874495A patent/NO173741C/no unknown
- 1987-10-28 DE DE87309528T patent/DE3786321T2/de not_active Expired - Fee Related
- 1987-10-28 AT AT87309528T patent/ATE90966T1/de not_active IP Right Cessation
- 1987-10-29 KR KR1019870011997A patent/KR970002166B1/ko not_active IP Right Cessation
- 1987-10-29 CA CA000550620A patent/CA1340263C/en not_active Expired - Fee Related
- 1987-10-29 DK DK198705670A patent/DK175183B1/da active
- 1987-10-29 JP JP62271959A patent/JP2561677B2/ja not_active Expired - Lifetime
-
1996
- 1996-03-26 JP JP8096200A patent/JP2922461B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DK567087A (da) | 1988-04-30 |
EP0266190A3 (en) | 1989-10-25 |
JP2561677B2 (ja) | 1996-12-11 |
NO874495D0 (no) | 1987-10-28 |
DK567087D0 (da) | 1987-10-29 |
DK175183B1 (da) | 2004-06-28 |
US4959318A (en) | 1990-09-25 |
KR880005270A (ko) | 1988-06-28 |
EP0266190B1 (en) | 1993-06-23 |
KR970002166B1 (ko) | 1997-02-24 |
EP0266190A2 (en) | 1988-05-04 |
ATE90966T1 (de) | 1993-07-15 |
NO173741C (no) | 1994-01-26 |
JP2922461B2 (ja) | 1999-07-26 |
JPH08252094A (ja) | 1996-10-01 |
NO173741B (no) | 1993-10-18 |
DE3786321D1 (de) | 1993-07-29 |
DE3786321T2 (de) | 1993-09-30 |
JPS6485084A (en) | 1989-03-30 |
CA1340263C (en) | 1998-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO874495L (no) | Ekspresjon av protein c. | |
NO862601D0 (no) | Ekspresjon av protein c. | |
KR850007275A (ko) | 기능성 인체인자 ⅷ의 제조방법 | |
ATE88501T1 (de) | Rekombinante dns-expressionsvektoren. | |
ES8800343A1 (es) | Un metodo para producir una proteina que contiene actividad biologica para coagulacion de sangre, mediada por factor viia | |
ATE391175T1 (de) | Multidrug resistenz gen | |
ATE284954T1 (de) | Hyaluronan synthase gen und seine verwendung | |
FI98829B (fi) | Menetelmä rekombinoidun proteiinikompleksin valmistamiseksi, jolla on humaanitekijä VIII:C-aktiivisuutta | |
EP0835661A3 (en) | Human interferon-Beta2A for use as a medicament | |
ES2078243T3 (es) | Mejoras en o relativas a la expresion eucariotica. | |
DE3855634T2 (de) | Innerhalb des alpha-Locus gelegenes T-Zell-Rezeptor-Gen und DNA-Konstruktionen | |
EP0336383A3 (en) | Novel recombinant human lymphotoxin | |
ATE181115T1 (de) | Stabilisierung von messenger-rns in tierischen zellen | |
AU6560886A (en) | DNA sequence containing the DNA sequence coding for human tissue plasminogen activator originating from human normal cells, recombinant DNA incorporating the DNA sequence, host cells transformed with the recombinant DNA, and process for producing human tissue plasminogen activator by use of the host cells | |
ATA435083A (de) | Das polypeptid interleukin-2 kodierendes gen, rekombinante, dieses gen enthaltende dna, diese rekombinante dna aufweisende zellinien und verfahren zur herstellung von interleukin-2 unter verwendung der genannten zellen | |
WO1991009951A3 (en) | Recombinant protein c with truncated light chain |